Supreme Court rejects Martin Shkreli fine appeal

Martin Shkreli in 2022 was banned from the pharmaceutical industry and ordered to disgorge profits earned from raising the price of the drug Daraprim.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *